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LIBRARY IMPACT STATEMENT (New Course Proposal)
LIBRARIAN’S ASSESSMENT
Subject selectors will complete this form as requested, assessing library materials and collections as
detailed below. Send one copy of the assessment to the faculty member who requested it. Send one
copy of the assessment to the Collection Management Officer.

Program: MLS 572
Department, College: Cell & Molecular Biology. CELS
Faculty Member: Professor Gregory Paquette
Date returned to Faculty: September 29, 2011
Librarian Completing Assessment: Michael A. Cerbo II
Collection Management Officer: Professor Joanna Burkhardt

This course is titled “Vaccines and Biologics” and has been offered in the past as a “special
topics” course. The Professor expects the students to conduct some research using books,
periodicals and other resources in the subject area. The major subjects that will be covered
include vaccine research, bioinformatics and immunogenicity. Grading will consist of
participation, a presentation, midterm and a hypothetical research paper. This course will be
required for the Masters in Medical Laboratory Science/Biotechnology Option
We are able to add whatever appropriate monographic needs might arise for the instructor. Our
monographic holdings in vaccines, pharmacology, biology and biotechnology as well as
healthcare are good and any additional materials can be garnered though our library consortium
(HELIN).
Access to journals in this field meets the needs of the course. Our online indexes and abstracts in
health sciences and biotechnology specifically and the sciences generally should more than meet
the demands of this course. Access to reference databases such as BIOSIS, ScienceDirect, Web
of Science, Clinical Pharmacology, and the more general Academic Search Complete are
available. We are unable to add any new journal titles except through a drop/add policy that
requires the department to identify a journal title (of equal value) it would like to drop from its
serials list to permit the addition of another. However, our current holdings in this field seem
sufficient.
Therefore, the librarian believes that the Library can support, bibliographically, the needs of the
students to be able to acquire the most out of this course.
Michael A. Cerbo II
Biology Bibliographer
29 September 2011

